ArticleFrontiers in bioengineering and biotechnology2024
U.S. public opinion about the safety of gene editing in the agriculture and medical fields and the amount of evidence needed to improve opinions.
Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 14 citations in OpenAlex.
- Understanding Acceptance of Genome-Edited Crops and Foods: The Role of Trust, Attitudes, and Perceived Literacy in Italy.Foods (Basel, Switzerland) · 2026Article
- Public acceptance of genome editing in Saudi Arabia is driven by therapeutic benefit despite limited awareness.Frontiers in medicine · 2026Article
- From Blog to lab: testing messages to shift public opinion on gene editing.Frontiers in bioengineering and biotechnology · 2026Article
- Analysis of the public perception and acceptance of gene-editing technology and gene-edited agricultural products in South Korea.GM crops & food · 2025Article
- Preventive Immunology for Livestock and Zoonotic Infectious Diseases in the One Health Era: From Mechanistic Insights to Innovative Interventions.Veterinary sciences · 2025Review
- What's in (y)our food? - Occurrence of GM-containing foods on the Nigerian market and compliance with national regulations.Journal, genetic engineering & biotechnology · 2025Article
- Latin America: a hub for agrobiotechnological innovations.Annals of botany · 2025Review
- Review
- Understanding the Factors Driving Consumers' Willingness to Pay for Gene-Edited Foods in China.Foods (Basel, Switzerland) · 2024Article
- A review and outlook on expression of animal proteins in plants.Frontiers in plant science · 2024Review
- Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19.Frontiers in public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.